Clinical Trial Update: ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ZYG24002 Lotion in adults with mild to moderate seborrheic dermatitis to assess safety, tolerability, pharmacokinetics and pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seborrheic Dermatitis

Drugs mentioned

• ZYG24002 Lotion

Snippet

Sponsor: Sinomune Pharmaceutical Co., Ltd | Conditions: Seborrheic Dermatitis | Phase 1 | Status: NOT_YET_RECRUITING